New Jersey S 1080: Prohibits substitution of prescribed epilepsy drugs by pharmacists without prior notification to and written consent of physician and patient.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2020-01-30)

State: New Jersey · Session: 219 · Bill: S 1080

Subjects: PHARMACEUTIC

Sponsors: Vitale, Joseph F.

View New Jersey S 1080 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.